Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W CLARKE

Showing results (791-800 of 856) with videos related to

Pageof 86
Sort By:
Trials|May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocolsFrancesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2025
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III studyK Fizazi, N W Clarke, M De Santis, et al.
European Urology|August 31, 2024
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Placenta|September 5, 2025
Perturbation of the ovine placental transcriptome occurs at sub-therapeutic exposures to antenatal steroid therapyErin L Johnson, Haruo Usuda, Sean W D Carter, et al.
The Lancet. Oncology|March 29, 2012
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trialNicholas D James, Matthew R Sydes, Malcolm D Mason, et al.
Science Advances|November 22, 2023
Elastomeric vitrimers from designer polyhydroxyalkanoates with recyclability and biodegradabilityRobin M Cywar, Chen Ling, Ryan W Clarke, et al.
Circulation|August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized TrialRenato D Lopes, Celestia S Higano, Susan F Slovin, et al.
European Urology|July 3, 2014
Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trialGerhardt Attard, Matthew R Sydes, Malcolm D Mason, et al.
Nucleic Acids Research|December 14, 2024
MirGeneDB 3.0: improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families and updated covariance modelsAlexander W Clarke, Eirik Høye, Anju Angelina Hembrom, et al.
Pageof 86

Showing results (791-800 of 856) with videos related to

Sort By:
Pageof 86
Trials|May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocolsFrancesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2025
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III studyK Fizazi, N W Clarke, M De Santis, et al.
European Urology|August 31, 2024
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Placenta|September 5, 2025
Perturbation of the ovine placental transcriptome occurs at sub-therapeutic exposures to antenatal steroid therapyErin L Johnson, Haruo Usuda, Sean W D Carter, et al.
The Lancet. Oncology|March 29, 2012
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trialNicholas D James, Matthew R Sydes, Malcolm D Mason, et al.
Science Advances|November 22, 2023
Elastomeric vitrimers from designer polyhydroxyalkanoates with recyclability and biodegradabilityRobin M Cywar, Chen Ling, Ryan W Clarke, et al.
Circulation|August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized TrialRenato D Lopes, Celestia S Higano, Susan F Slovin, et al.
European Urology|July 3, 2014
Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trialGerhardt Attard, Matthew R Sydes, Malcolm D Mason, et al.
Nucleic Acids Research|December 14, 2024
MirGeneDB 3.0: improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families and updated covariance modelsAlexander W Clarke, Eirik Høye, Anju Angelina Hembrom, et al.
Pageof 86